BioSpace News Archive

Canadians who are blind were looking forward to described video for all shows during prime-time hours starting in September 2019, as mandated by the Canadian Radio-Television and Telecommunications Commission (CRTC).

Clarkston Consulting announced that it will participate at SAPPHIRE NOW® and ASUG Annual Conference being held May 7-9 in Orlando, Florida in booth #1234.

Second Cohort of Phase 2a Study in Retinitis Pigmentosa Dosing Complete

Aquestive Therapeutics, Inc. reported financial results for the first quarter ended March 31, 2019 and provided an update on recent developments in its business.

No dose-limiting toxicities or safety concerns observed in first cohort of treated patients

IFM Therapeutics announced the completion of the previously-announced acquisition of its subsidiary, IFM Tre, by Novartis.

REGENXBIO Inc. announced it will present at the Bank of America Merrill Lynch 2019 Healthcare Conference on Wednesday, May 15, 2019, at the Encore Wynn Hotel, Las Vegas, NV:

Exhibits Collaboration Portal and Three Scientific Posters

Protagonist Therapeutics, Inc. announced the expansion of its worldwide license and collaboration agreement with Janssen Biotech, Inc. for the co-development and commercialization of PTG-200, Protagonist’s first-in-class, oral peptide IL-23 receptor antagonist, for all indications including inflammatory bowel disease (IBD).

The Green Organic Dutchman Holdings Ltd. is pleased to announce the Company’s strategic investment into the US beverage space as a co-founding investor and strategic partner in the newly formed Califormulations LLC.